-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Study Shows Sedentary Time Increases Cardiovascular Disease
Sedentary time negatively impacts heart health regardless of whether a person follows exercise guidelines.
-
Biomarkers May Help Predict Risk of Heart Failure in Patients With Atrial Fibrillation
A multicenter team led by the Brigham used patient data compiled from three large clinical trials to identify potential prognostic biomarkers that could be used to risk-stratify patients with atrial fibrillation based on their heart failure risk. First author Paul Haller, MD, PhD, discusses the study's implications.
-
One in Ten Home Hospital Patients With Heart Failure Requires Escalation of Care
Patients with heart failure who were enrolled in home hospital at Massachusetts General Hospital or Brigham and Women's Hospital had a 10% chance of requiring transfer for at least one night of traditional inpatient care, and this escalation of care was linked to increased healthcare utilization.
-
Cardiorenal Biomarkers Predict Major Complications in Patients With Type 2 Diabetes and Chronic Kidney Disease
James L. Januzzi, MD, and colleagues showed that among people with type 2 diabetes and albuminuria, baseline and follow-up concentrations of four biomarkers of cardiorenal stress individually and collectively predicted the risk of heart failure, progression of kidney disease, and related outcomes.
Heart Failure Contributors
-
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Recent Article
Cardiorenal Biomarkers Predict Major Complications in Patients With Type 2 Diabetes and Chronic Kidney Disease -
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Co-Director, Corrigan Minehan Heart Center, Director, Cardiac Surgery Clinical Service, Mass General Brigham
Recent Article
Treating Pericardial Disease